StockNews.AI
IDBA
StockNews.AI
2 days

Mandatory disclosure of holding and notice of trade in IDEX Biometrics – 23 August 2025

1. IDEX completed a private placement of 9,090,909 shares at NOK 3.30. 2. CEO Anders Storbråten and related companies invested significantly in the offering. 3. Storbråten now holds 13.81% of IDEX's total shares post-placement. 4. The private placement's details comply with Norwegian Securities Trading Act. 5. IDEX specializes in fingerprint biometrics for secure authentication solutions.

4m saved
Insight
Article

FAQ

Why Bullish?

Management's significant investment suggests confidence in the company's future performance, similar to precedent actions where insider buying correlated with price increases.

How important is it?

The article identifies significant insider purchasing, typically viewed positively as a sign of company stability and growth potential.

Why Short Term?

Investor sentiment may quickly respond to insider buying, often leading to short-term price rallies following such announcements.

Related Companies

NOKAAPLGOOGLMSFTAMZN
August 23, 2025 07:00 ET  | Source: IDEX BIOMETRICS ASA Reference is made to IDEX Biometrics ASA's disclosure on 21 July 2025 of a private placement of 9,090,909 shares at NOK 3.30 per share, split in two tranches. IDEX discloses the following information on behalf of primary insiders. In tranche 2 of the private placement, including underwriting shares, 4,813, 857 total shares. Pinchcliffe AS, a company closely related to CEO and CFO Anders Storbråten, subscribed to 469,255 shares, ISIN NO0013536078, at NOK 3.30 per share, and Anders Storbråten, CEO and CFO, subscribed to 703,883 shares, ISIN NO0013536078, at NOK 3.30 per share. After the subscription by Pinchcliffe and Anders Storbråten, Mr. Storbråten and close relations hold 7,195,898 or 13,81% shares of the total outstanding shares and votes in IDEX Biometrics after completion of Tranche 2. K-konsult AS, a company closely related to chair Morten Opstad, subscribed to153,343 shares, ISIN NO0013536078, at NOK 3.30 per share, and Morten Opstad, chair, subscribed to 50,000 shares, ISIN NO0013536078, at NOK 3.30 per share. Contact personAnders Storbråten, CEO and CFO Tel: +47 4163 8582E-mail: ir@idexbiometrics.com About IDEX BiometricsIDEX Biometrics ASA (OSE: IDEX) is a global technology leader in fingerprint biometrics, offering authentication solutions across payments, access control, and digital identity. Our solutions bring convenience, security, peace of mind and seamless user experiences to the world. Built on patented and proprietary sensor technologies, integrated circuit designs, and software, our biometric solutions target card-based applications for payments and digital authentication. As an industry-enabler we partner with leading card manufacturers and technology companies to bring our solutions to market. For more information, visit www.idexbiometrics.com About this noticeThis notice was issued by Kjell-Arne Besseberg, COO, on 23 August 2025 at 13:00 CEST on behalf of IDEX Biometrics ASA. The information about the lending shall be disclosed according to article 19 no. 3 of the EU Market Abuse Regulation (EU 596/2014). The information about shareholding shall be disclosed according to section 4-2 of the Norwegian Securities Trading Act (STA). The information is published in accordance with section 5‑12 of the Norwegian Securities Trading Act.

Related News